These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

715 related articles for article (PubMed ID: 25483672)

  • 21. EV71 vaccines: a first step towards multivalent hand, foot and mouth disease vaccines.
    Klein MH
    Expert Rev Vaccines; 2015 Mar; 14(3):337-40. PubMed ID: 25536888
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of a high-titered antibody response using HIV gag-EV71 VP1-based virus-like particles with the capacity to protect newborn mice challenged with a lethal dose of enterovirus 71.
    Wang X; Dong K; Long M; Lin F; Gao Z; Wang L; Zhang Z; Chen X; Dai Y; Wang H; Zhang H
    Arch Virol; 2018 Jul; 163(7):1851-1861. PubMed ID: 29582164
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Broadly Cross-protective Vaccine Presenting the Neighboring Epitopes within the VP1 GH Loop and VP2 EF Loop of Enterovirus 71.
    Xu L; He D; Yang L; Li Z; Ye X; Yu H; Zhao H; Li S; Yuan L; Qian H; Que Y; Kuo Shih JW; Zhu H; Li Y; Cheng T; Xia N
    Sci Rep; 2015 Aug; 5():12973. PubMed ID: 26243660
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chimeric enterovirus 71 virus-like particle displaying conserved coxsackievirus A16 epitopes elicits potent immune responses and protects mice against lethal EV71 and CA16 infection.
    Luo J; Huo C; Qin H; Hu J; Lei L; Pan Z
    Vaccine; 2021 Jul; 39(30):4135-4143. PubMed ID: 34116877
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Neonatal Murine Model of Coxsackievirus A6 Infection for Evaluation of Antiviral and Vaccine Efficacy.
    Zhang Z; Dong Z; Wei Q; Carr MJ; Li J; Ding S; Tong Y; Li D; Shi W
    J Virol; 2017 May; 91(9):. PubMed ID: 28250116
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel combined vaccine based on monochimeric VLP co-displaying multiple conserved epitopes against enterovirus 71 and varicella-zoster virus.
    Wu Y; Zhu R; Xu L; Li Y; Li S; Yu H; Li S; Zhu H; Cheng T; Xia N
    Vaccine; 2017 May; 35(20):2728-2735. PubMed ID: 28408118
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost-effectiveness of bivalent versus monovalent vaccines against hand, foot and mouth disease.
    Liu D; Leung K; Jit M; Yu H; Yang J; Liao Q; Liu F; Zheng Y; Wu JT
    Clin Microbiol Infect; 2020 Mar; 26(3):373-380. PubMed ID: 31279839
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunogenicity studies of bivalent inactivated virions of EV71/CVA16 formulated with submicron emulsion systems.
    Lin CW; Liu CC; Lu TC; Liu SJ; Chow YH; Chong P; Huang MH
    Biomed Res Int; 2014; 2014():670506. PubMed ID: 25006583
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potential of a bivalent vaccine for broad protection against enterovirus 71 and coxsackie virus 16 infections causing hand, foot, and mouth disease.
    Yi EJ; Kim YI; Song JH; Ko HJ; Ahn SH; Lee HJ; Suh B; Yu J; Park J; Lee YJ; Jung EJ; Chang SY
    Vaccine; 2023 Sep; 41(41):6055-6063. PubMed ID: 37648607
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Active immunization with a Coxsackievirus A16 experimental inactivated vaccine induces neutralizing antibodies and protects mice against lethal infection.
    Cai Y; Liu Q; Huang X; Li D; Ku Z; Zhang Y; Huang Z
    Vaccine; 2013 Apr; 31(18):2215-21. PubMed ID: 23499596
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protective effect of enterovirus‑71 (EV71) virus‑like particle vaccine against lethal EV71 infection in a neonatal mouse model.
    Cao L; Mao F; Pang Z; Yi Y; Qiu F; Tian R; Meng Q; Jia Z; Bi S
    Mol Med Rep; 2015 Aug; 12(2):2473-80. PubMed ID: 25936344
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunological evaluation and comparison of different EV71 vaccine candidates.
    Chou AH; Liu CC; Chang JY; Lien SP; Guo MS; Tasi HP; Hsiao KN; Liu SJ; Sia C; Wu SC; Lee MS; Hsiao CH; Wang JR; Chow YH; Chong P
    Clin Dev Immunol; 2012; 2012():831282. PubMed ID: 23008736
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The immunogenicity and protection effect of an inactivated coxsackievirus A6, A10, and A16 vaccine against hand, foot, and mouth disease.
    Lim H; In HJ; Lee JA; Sik Yoo J; Lee SW; Chung GT; Choi YK; Chung JK; Cho SJ; Lee JW
    Vaccine; 2018 Jun; 36(24):3445-3452. PubMed ID: 29739716
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunological and biochemical characterizations of coxsackievirus A6 and A10 viral particles.
    Liu CC; Guo MS; Wu SR; Lin HY; Yang YT; Liu WC; Chow YH; Shieh DB; Wang JR; Chong P
    Antiviral Res; 2016 May; 129():58-66. PubMed ID: 26899790
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A safety study of inactivated Enterovirus 71 vaccine.
    Zhou XB; Lu JJ; Jiang YS; Huo Y; Wang JF; Zhou KF; Li B
    Hum Vaccin Immunother; 2013 Jul; 9(7):1430-7. PubMed ID: 23571172
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Production of EV71 vaccine candidates.
    Chong P; Hsieh SY; Liu CC; Chou AH; Chang JY; Wu SC; Liu SJ; Chow YH; Su IJ; Klein M
    Hum Vaccin Immunother; 2012 Dec; 8(12):1775-83. PubMed ID: 22992566
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coxsackievirus A16-like particles produced in Pichia pastoris elicit high-titer neutralizing antibodies and confer protection against lethal viral challenge in mice.
    Zhang C; Liu Q; Ku Z; Hu Y; Ye X; Zhang Y; Huang Z
    Antiviral Res; 2016 May; 129():47-51. PubMed ID: 26902108
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhanced neutralizing antibody response induced by inactivated enterovirus 71 in cynomolgus monkeys.
    In HJ; Lim H; Lee JA; Lee SR; Jin YB; Jeong KJ; Hyeon JY; Yoo JS; Lee JW; Choi YK; Lee SW
    PLoS One; 2018; 13(10):e0202552. PubMed ID: 30278051
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of an inactivated bivalent vaccine for enterovirus 71 and coxsackievirus A16 in mice immunized intradermally.
    Fan S; Liao Y; Jiang G; Wang L; Zhao H; Yu L; Xu X; Li D; Zhang Y; Li Q
    Vaccine; 2021 Jan; 39(3):596-604. PubMed ID: 33342637
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Study of integrated protective immunity induced in rhesus macaques by the intradermal administration of a bivalent EV71-CA16 inactivated vaccine.
    Fan S; Liao Y; Jiang G; Jiang L; Wang L; Xu X; Feng M; Yang E; Zhang Y; Cui W; Li Q
    Vaccine; 2020 Feb; 38(8):2034-2044. PubMed ID: 31982260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.